Biocryst Pharmaceuticals (BCRX)'s 30-day implied volatility (IV30) was 43.2% at the close on November 20, 2026, up from 39.8% the day before, against a 52-week range of 31.2% to 85.1%. Its 20-day historical volatility was 37.7%.
Data as of November 20, 2026.